Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

The first patients completed their treatment a long time ago. Treatments were for 3 days at the start and as of March 5 "Fifteen patients have already been dosed in the trial."
http://www.ipharminc.com/press-release/2021/3/5/recruitment-and-enrollment-underway-at-eight-sites-for-innovation-pharmas-phase-2-clinical-trial-of-brilacidin-for-covid-19

Not only were those 15 patients finished with their treatments as of March 5th but whether their treatment met primary endpoints should have been assessable by April 3rd.

Then, on April 5th, we heard that "Enrollment has reached 25 percent in the Company’s ~120-patient Phase 2 COVID-19 clinical trial" and patients after that would receive 5 day treatments.
So 30 patients would have been dosed and either met or not met the primary endpoints by May 4th.